A randomised-controlled clinical trial to evaluate the effectiveness and safety of combining nicotine patches with e-cigarettes (with and without nicotine) plus behavioural support, on smoking abstinence
Tobacco smoking is one of the greatest modifiable risks to health worldwide. Each year millions of people die prematurely as a result of tobacco smoke exposure. Most smokers want to quit and many try each year. However, the chances of long-term cessation are low, especially for highly dependent smokers. In an effort to help more smokers achieve the goal of quitting for life, the Addiction Research Programme investigates novel approaches to supporting people to change their behaviour.
These studies test the effectiveness of novel delivery systems, variations of delivery of standard treatments, or novel treatments. The research team includes public health physicians and smoking cessation researchers, and has many collaborative networks nationally and internationally.